´ëÇÑÈäºÎ¿Ü°úÇÐȸ ECMO ¿¬±¸È¸ ½ÉÆ÷Áö¿ò : 2020-11-28±³À°ÀÏÀÚ : 2020-11-28
±³À°Àå¼Ò : ÄÚ¿¢½º
±³À°ÁÖÁ¦ :
´ëÇÑÈäºÎ¿Ü°úÇÐȸ ECMO ¿¬±¸È¸ ½ÉÆ÷Áö¿ò ÁÖÃÖ±â°ü : ´ëÇÑÈäºÎ¿Ü°úÇÐȸ
´ã´çÀÚ : ¹ÚÁÖ¿¬
¿¬¶ôó : 02-3410-3489
À̸ÞÀÏ :
sd000.park@naver.com ±³À°Á¾·ù : ÈäºÎ¿Ü°ú
Âü¼®¿¹»óÀοø : 300¸í
Èñ¸ÁÆòÁ¡ : 2Á¡
Áö¿ª :
¼¿ïƯº°½Ã±³À°½Ã°£ : 2 ½Ã°£ 30ºÐ
¼¼ºÎ¼ö°·á : 30,000¿ø
ºñ°í ¿ø³»:¹«·á°£È£»ç/ÀÇ·á±â»ç/Àü°øÀÇ : 1¸¸¿øÀü¹®ÀÇ : 3¸¸¿ø
±¸ºÐ ¿ùÀÏ °ÀÇ½Ç ½Ã°£ ±³À°Á¦¸ñ °»ç¸í(¼Ò¼Ó) Çʼö°ú¸ñ
±âŸ 11¿ù 28ÀÏ 403È£ 09:00~09:10 ÀÎ»ç ±è¿õÇÑ(¼¿ï´ë)
±³À°½Ã°£ 11¿ù 28ÀÏ 403È£ 09:10~09:25 OHCA: Patient ion Á¤ÀǼ®(ÀÎÁ¦´ë)
±³À°½Ã°£ 11¿ù 28ÀÏ 403È£ 09:25~09:40 Evidences of Target Temperature Management after cardiac arrest °ÇÊÁ¦(¿ï»ê´ë)
±³À°½Ã°£ 11¿ù 28ÀÏ 403È£ 09:40~09:55 Cannulation techniques for ECPR À̼®ÀÎ(°¡Ãµ´ë)
±³À°½Ã°£ 11¿ù 28ÀÏ 403È£ 09:55~10:10 ECPR and organ donation Á¤Àç½Â(°í·Á´ë)
±³À°½Ã°£ 11¿ù 28ÀÏ 403È£ 10:10~10:25 Panel Discussion ±èÁؼº(¼¿ï´ë)
ÈÞ½Ä 11¿ù 28ÀÏ 403È£ 10:25~10:35 Break ()
±³À°½Ã°£ 11¿ù 28ÀÏ 403È£ 10:35~10:50 ECMO bridge to LVAD or HT Á¶¾çÇö(¼º±Õ°ü´ë)
±³À°½Ã°£ 11¿ù 28ÀÏ 403È£ 10:50~11:05 ECMO for ARDS: What ¼Û½Âȯ(ºÎ»ê´ë)
±³À°½Ã°£ 11¿ù 28ÀÏ 403È£ 11:05~11:20 ECMO for COIVD 19: Evidences and Experience Á¤Àμ®(Àü³²´ë)
±³À°½Ã°£ 11¿ù 28ÀÏ 403È£ 11:20~11:35 Looking for the best anticoagulation strategy of ECMO ±è¼öÇö(¼¿ï´ë)
±³À°½Ã°£ 11¿ù 28ÀÏ 403È£ 11:35~11:50 Panel Discussion ±èµµÇü(ºÎ»ê´ë)
±âŸ 11¿ù 28ÀÏ 403È£ 11:50~12:00 ¸¶¹«¸® ()